首页|AST/PLT比值指数与乙肝肝硬化抗病毒治疗患者肝癌发生的关系

AST/PLT比值指数与乙肝肝硬化抗病毒治疗患者肝癌发生的关系

扫码查看
目的 分析谷草转氨酶(AST)/血小板计数(PLT)比值指数与乙肝肝硬化抗病毒治疗患者肝癌发生的关系.方法 回顾性分析,收集确诊后接受抗病毒治疗和2年随访的103例乙肝肝硬化患者资料,患者人口学资料、治疗相关资料、实验室指标检查结果等资料均保存完整.仔细查阅患者资料,记录其随访期间肝癌发生情况,将发生纳入肝癌组,未发生纳入非肝癌组,记录患者人口学资料与临床资料.记录并比较两组患者抗病毒治疗前的AST、PLT水平,计算AST/PLT比值指数.经Logistic回归分析检验AST、PLT水平及AST/PLT比值与乙肝肝硬化抗病毒治疗患者肝癌发生的关系.结果 103例患者在2年随访期间,共发生肝癌26例,发生率为25.24%(26/103).肝癌组与非肝癌组性别、年龄、体质量指数、饮酒史及病理类型等资料比较均无统计学差异(P>0.05).肝癌组AST水平、AST/PLT比值指数高于非肝癌组,PLT水平低于非肝癌组,差异有统计学意义(P<0.05);经回归分析检验结果显示,AST、PLT水平及AST/PLT比值与乙肝肝硬化抗病毒治疗患者肝癌的发生有关,是肝癌发生的影响因素(P<0.05),其中AST/PLT比值可作为独立风险因子.结论 AST/PLT比值指数与乙肝肝硬化抗病毒治疗患者肝癌发生有关,是患者肝癌发生的独立风险因子,应引起临床重视.
The Relationship Between AST/PLT Ratio Index and the Risk of Liver Cancer in Patients with Hepatitis B Cirrhosis Treated with Antiviral Therapy
Objective To analyze the relationship between the ratio index of aspartate aminotransferase(AST)/platelet count(PLT)and the incidence of liver cancer in patients with hepatitis B cirrhosis treated with antiviral therapy.Methods Ret-rospective analysis was conducted to collect the data of 103 patients with hepatitis B cirrhosis who received antiviral treatment af-ter being diagnosed were followed up for 2 years.The demographic data,treatment related data,laboratory index examination re-sults and other data of patients were kept intact.The patient's data were carefully reviewed,and the occurrence of liver cancer dur-ing the follow-up period was recorded.The occurrence was included in the liver cancer group,and the non liver cancer group was included.The patients demographic data and clinical data were recorded.The AST and PLT levels of the two groups before antivi-ral treatment were recorded and compared,and the AST/PLT ratio index was calculated.Logistic regression analysis was used to examine the relationship between AST,PLT levels and AST/PLT ratio and the occurrence of liver cancer in patients with hepatitis B cirrhosis treated with antiviral therapy.Results During the 2-year follow-up period of 103 patients,a total of 26 cases of liver cancer occurred,with an incidence rate of 25.24%(26/103).There was no statistical significant difference in gender,age,body mass index,drinking history,and pathological type between the liver cancer group and the non liver cancer group(P>0.05).The AST level and AST/PLT ratio index in the liver cancer group were higher than those in the non liver cancer group,while the PLT level was lower than that in the non liver cancer group,with a statistical significant difference(P<0.05).The results of regression analysis showed that AST,PLT level and AST/PLT ratio were related to the occurrence of liver cancer in patients with hepatitis B cirrhosis treated with antiviral therapy,and were the influencing factors of liver cancer(P<0.05),of which AST/PLT ratio could be regarded as an independent risk factor.Conclusion AST/PLT ratio index is related to the occurrence of liver cancer in pa-tients with hepatitis B cirrhosis treated with antiviral therapy,and it is an independent risk factor for the occurrence of liver cancer in patients,which should be paid attention to clinically.

Hepatitis BLiver cirrhosisAntiviral therapyLiver cancerAspartate aminotransferasePlatelet count

赵润根、井贺楠、张越亚

展开 >

467000 平煤神马医疗集团总医院

乙肝 肝硬化 抗病毒治疗 肝癌 谷草转氨酶 血小板计数

2024

实用癌症杂志
江西省肿瘤医院 江西省肿瘤研究所

实用癌症杂志

影响因子:1.241
ISSN:1001-5930
年,卷(期):2024.39(10)